Fig. 3From: Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patientsSurvival analysis of elderly breast cancer patients according to IL-5 and/or IL-17 production by Her-2-stimulated CD4+ T-cells. a patients grouped according to IL-5 and/or IL-17 production in all patients and b in non-metastatic patients onlyBack to article page